EVLO - Evelo Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EVLO is currently covered by 3 analysts

Evelo Biosciences's activity chart (see below) currently has 15 price targets and 15 ratings on display. The stock rating distribution of EVLO is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.19% with an average time for these price targets to be met of 85.29 days.

Highest price target for EVLO is $55, Lowest price target is $7.

Most recent stock forecast was given by VIKRAM PUROHIT from MORGAN STANLEY on 26-Jul-2023. First documented stock forecast 04-Jun-2018.

Currently out of the existing stock ratings of EVLO, 3 are a BUY (60%), 2 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2

$1.95 (3900.00%)

$80

2 years 11 months 12 days ago
(26-Jul-2023)

1/2 (50%)

$-5.88 (-74.62%)

83

Buy

$10

$9.96 (24900.00%)

$10

3 years 3 months 21 days ago
(17-Mar-2023)

2/2 (100%)

$4.82 (93.05%)

79

Buy

$5

$4.96 (12400.00%)

3 years 3 months 22 days ago
(16-Mar-2023)

1/1 (100%)

$-0.98 (-16.39%)

4

Buy

$280

3 years 5 months 7 days ago
(01-Feb-2023)

1/3 (33.33%)

$120.6 (75.66%)

6

Buy

$50

$49.95 (99900.00%)

$12

3 years 7 months 22 days ago
(16-Nov-2022)

3/4 (75%)

$4.2 (9.17%)

100

Show more analysts

Please expand the browser size to see the chart

What is EVLO (Evelo Biosciences) average time for price targets to be met?

On average it took 85.29 days on average for the stock forecasts to be realized with a an average price target met ratio 76.19

Which analyst has the current highest performing score on EVLO (Evelo Biosciences) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on EVLO (Evelo Biosciences) with a proven track record?

GARY NACHMAN

Which analyst has the most public recommendations on EVLO (Evelo Biosciences)?

Keay Nakae works at CHARDAN CAPITAL and has 2 price targets and 7 ratings on EVLO

Which analyst is the currently most bullish on EVLO (Evelo Biosciences)?

Matthew Harrison with highest potential upside - $259.95

Which analyst is the currently most reserved on EVLO (Evelo Biosciences)?

Chris Howerton with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?